About

It is not “just a headache”

article

Understanding Migraine and Cluster Headache

Migraine

Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Although migraine feels different for each person, episodes typically last 4 to 72 hours and are characterized by a severe throbbing headache on one side of the head that worsens with physical activity. Accompanying symptoms include nausea, vomiting, increased sensitivity to light, sound or odors and cognitive and emotional disturbances, often requiring bed rest. Migraine mainly affects women between the ages of 20 and 50.

Chronic migraine is defined as having headaches at least 15 days a month, with a minimum of eight days meeting migraine criteria. It is important to note that not all people with chronic migraine have headache-free periods, also known as "crystal clear days". Some people endure unrelenting migraine symptoms without finding relief. It is important to understand that having migraine is not your fault; it is a genetic influence on a neurological disease.

Cluster headache

Cluster headache is a severe one-sided headache that causes excruciating pain behind the eye, often accompanied by tearing, sweating, drooping eyelids and nasal congestion. It is a severe neurological disorder that affects 1 in 1000 people. Attacks last 15 to 180 minutes and may occur one to eight times per day. Cluster headache is predominantly a male disorder, although the ratio of men to women has been decreasing and is now about 2:1. Cluster attacks are extremely disruptive to daily life, sometimes causing persistent headaches between attacks. Genetics play a role in their development and severity. Cluster headache is associated with a higher risk of suicidal thoughts and attempts, earning it the nickname "suicide headache". These attacks occur in clusters of one to two months, with remission periods varying from months to years. In chronic cases of cluster headache, there are no remissions or they last less than three months.

References:
  • Gupta J, Gaurkar S S. Migraine: An Underestimated Neurological Condition Affecting Billions. Cureus 14(8): e28347. doi:10.7759/cureus.28347 (August 24, 2022)
  • Steiner, T.J., Stovner, L.J., Vos, T. et al. Migraine is first cause of disability in under 50s: will health politicians now take notice?. J Headache Pain 19, 17 (2018)
  • Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202
  • Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. Journal of Headache and Pain. 2019;20(1). doi:10.1186/s10194-019-1017-9
  • Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631-649. doi:10.1016/j.ncl.2019.06.001
  • Burstein R, Jakubowski M, Rauch SD. The science of migraine. J Vestib Res. 2011;21(6):305-314. doi:10.3233/VES2012-0433
  • Schroeder RA, Brandes J, Buse DC, et al. Sex and Gender Differences in Migraine - Evaluating Knowledge Gaps. J Womens Health. 2018;27(8):965-973. doi:10.1089/jwh.2018.7274
  • Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Migraine: Genetic Variants and Clinical Phenotypes. Curr Med Chem. 2019;26(34):6207-6221
  • American Headache Society. New research on the burden of cluster headache. (March 21, 2023)
  • Rozen TD, Fishman RS. Cluster Headache in the United States of America: Demographics, Clinical Characteristics, Triggers, Suicidality, and Personal Burden. Headache. 2012;52(1):99-113. doi:10.1111/j.1526-4610.2011.02028.x
  • Jürgens TP. Comment: Sex-specific differences in cluster headache -: Not a males-only disorder. Neurology. 2017;88(11):1074. doi:10.1212/WNL.0000000000003723
  • D’Amico D, Raggi A, Grazzi L, Lambru G. Disability, Quality of Life, and Socioeconomic Burden of Cluster Headache: A Critical Review of Current Evidence and Future Perspectives. Headache. 2020;60(4):809-818. doi:10.1111/head.13784
  • Göbel CH, Karstedt S, Heinze A, Koch B, Göbel H. Phenotype of Cluster Headache : Clinical Variability, Persisting Pain Between Attacks , and Comorbidities - An Observational Cohort Study in 825 Patients. Published online 2021. doi:10.1007/ s40122-021-00267-8
  • Ji Lee M, Cho SJ, Wook Park J, et al. Increased suicidality in patients with cluster headache. Cephalalgia. 2019;39(10):1249-1256. doi:10.1177/0333102419845660

Page Title (H1)

Understanding Migraine and Cluster Headache

Migraine

Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Although migraine feels different for each person, episodes typically last 4 to 72 hours and are characterized by a severe throbbing headache on one side of the head that worsens with physical activity. Accompanying symptoms include nausea, vomiting, increased sensitivity to light, sound or odors and cognitive and emotional disturbances, often requiring bed rest. Migraine mainly affects women between the ages of 20 and 50.

Chronic migraine is defined as having headaches at least 15 days a month, with a minimum of eight days meeting migraine criteria. It is important to note that not all people with chronic migraine have headache-free periods, also known as "crystal clear days". Some people endure unrelenting migraine symptoms without finding relief. It is important to understand that having migraine is not your fault; it is a genetic influence on a neurological disease.

Cluster headache

Cluster headache is a severe one-sided headache that causes excruciating pain behind the eye, often accompanied by tearing, sweating, drooping eyelids and nasal congestion. It is a severe neurological disorder that affects 1 in 1000 people. Attacks last 15 to 180 minutes and may occur one to eight times per day. Cluster headache is predominantly a male disorder, although the ratio of men to women has been decreasing and is now about 2:1. Cluster attacks are extremely disruptive to daily life, sometimes causing persistent headaches between attacks. Genetics play a role in their development and severity. Cluster headache is associated with a higher risk of suicidal thoughts and attempts, earning it the nickname "suicide headache". These attacks occur in clusters of one to two months, with remission periods varying from months to years. In chronic cases of cluster headache, there are no remissions or they last less than three months.

REFERENCES:
  • Gupta J, Gaurkar S S. Migraine: An Underestimated Neurological Condition Affecting Billions. Cureus 14(8): e28347. doi:10.7759/cureus.28347 (August 24, 2022)
  • Steiner, T.J., Stovner, L.J., Vos, T. et al. Migraine is first cause of disability in under 50s: will health politicians now take notice?. J Headache Pain 19, 17 (2018)
  • Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi:10.1177/0333102417738202
  • Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. Journal of Headache and Pain. 2019;20(1). doi:10.1186/s10194-019-1017-9
  • Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631-649. doi:10.1016/j.ncl.2019.06.001
  • Burstein R, Jakubowski M, Rauch SD. The science of migraine. J Vestib Res. 2011;21(6):305-314. doi:10.3233/VES2012-0433
  • Schroeder RA, Brandes J, Buse DC, et al. Sex and Gender Differences in Migraine - Evaluating Knowledge Gaps. J Womens Health. 2018;27(8):965-973. doi:10.1089/jwh.2018.7274
  • Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Migraine: Genetic Variants and Clinical Phenotypes. Curr Med Chem. 2019;26(34):6207-6221
  • American Headache Society. New research on the burden of cluster headache. (March 21, 2023)
  • Rozen TD, Fishman RS. Cluster Headache in the United States of America: Demographics, Clinical Characteristics, Triggers, Suicidality, and Personal Burden. Headache. 2012;52(1):99-113. doi:10.1111/j.1526-4610.2011.02028.x
  • Jürgens TP. Comment: Sex-specific differences in cluster headache -: Not a males-only disorder. Neurology. 2017;88(11):1074. doi:10.1212/WNL.0000000000003723
  • D’Amico D, Raggi A, Grazzi L, Lambru G. Disability, Quality of Life, and Socioeconomic Burden of Cluster Headache: A Critical Review of Current Evidence and Future Perspectives. Headache. 2020;60(4):809-818. doi:10.1111/head.13784
  • Göbel CH, Karstedt S, Heinze A, Koch B, Göbel H. Phenotype of Cluster Headache : Clinical Variability, Persisting Pain Between Attacks , and Comorbidities - An Observational Cohort Study in 825 Patients. Published online 2021. doi:10.1007/ s40122-021-00267-8
  • Ji Lee M, Cho SJ, Wook Park J, et al. Increased suicidality in patients with cluster headache. Cephalalgia. 2019;39(10):1249-1256. doi:10.1177/0333102419845660

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

  • Opsomming List Item
  • Opsomming List Item
  • Opsomming List Item
  1. Opsomming List Item
  2. Opsomming List Item
  3. Opsomming List Item
Block Quote
Other articles

Some more articles you might like...

NEWS

Salvia Selected for MedTech Innovator Accelerator 2024

Salvia BioElectronics is one of the companies selected for the MedTech Innovator Accelerator 2024. "We are absolutely thrilled," says Salvia CEO Hubert Martens. "With over 1300 applicants, only the top 5% made it through the rigorous selection process; this is an amazing group to be a part of. We're looking forward to connecting with like-minded entrepreneurs and are excited to have the opportunity to learn from the best in class and get expert support to further detail and pressure test our commercialization plans."

Read article